Sustained presence of lipid peroxides in the circulation and their pla
sma carrier is a controversial issue. Particularly, there is no firm e
vidence for an increased plasma lipid peroxide level in patients with
atherosclerosis. In this study, a strong correlation was found between
plasma total lipid hydroperoxide and lipid hydroperoxide content of I
DL cholesterol (r = 0.882; p < 0.001; n = 16). Lipid hydroperoxides in
plasma were carried almost exclusively (89%) in LDL. In 70 patients t
ested 3 months after coronary artery bypass graft surgery with a speci
fic assay, plasma lipid hydroperoxide levels were significantly increa
sed when compared with matched healthy controls (4.31 +/- 0.23 nmol/ml
and 2.34 +/- 0.13 nmol/ml, p < 0.0001, patients vs controls, respecti
vely). These concentrations are 10 times lower than those detected by
the nonspecific thiobarbituric acid assay. However, considering the in
vitro concentration range in which oxidized IDL exerts important athe
rogenic effects, the elevated plasma lipid hydroperoxide levels measur
ed in atherosclerotic patients have pathologic significance.